Your browser doesn't support javascript.
loading
Swiss public health measures associated with reduced SARS-CoV-2 transmission using genome data.
Nadeau, Sarah A; Vaughan, Timothy G; Beckmann, Christiane; Topolsky, Ivan; Chen, Chaoran; Hodcroft, Emma; Schär, Tobias; Nissen, Ina; Santacroce, Natascha; Burcklen, Elodie; Ferreira, Pedro; Jablonski, Kim Philipp; Posada-Céspedes, Susana; Capece, Vincenzo; Seidel, Sophie; Santamaria de Souza, Noemi; Martinez-Gomez, Julia M; Cheng, Phil; Bosshard, Philipp P; Levesque, Mitchell P; Kufner, Verena; Schmutz, Stefan; Zaheri, Maryam; Huber, Michael; Trkola, Alexandra; Cordey, Samuel; Laubscher, Florian; Gonçalves, Ana Rita; Aeby, Sébastien; Pillonel, Trestan; Jacot, Damien; Bertelli, Claire; Greub, Gilbert; Leuzinger, Karoline; Stange, Madlen; Mari, Alfredo; Roloff, Tim; Seth-Smith, Helena; Hirsch, Hans H; Egli, Adrian; Redondo, Maurice; Kobel, Olivier; Noppen, Christoph; du Plessis, Louis; Beerenwinkel, Niko; Neher, Richard A; Beisel, Christian; Stadler, Tanja.
Afiliação
  • Nadeau SA; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Vaughan TG; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Beckmann C; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Topolsky I; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Chen C; Viollier AG, 4123 Allschwil, Switzerland.
  • Hodcroft E; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Schär T; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Nissen I; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Santacroce N; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Burcklen E; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Ferreira P; Institute for Social and Preventive Medicine, University of Bern, 3012 Bern, Switzerland.
  • Jablonski KP; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Posada-Céspedes S; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Capece V; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Seidel S; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Santamaria de Souza N; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Martinez-Gomez JM; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Cheng P; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Bosshard PP; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Levesque MP; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Kufner V; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Schmutz S; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Zaheri M; Department of Biosystems Science and Engineering, ETH Zurich, 4058 Basel, Switzerland.
  • Huber M; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Trkola A; Department of Biology, ETH Zurich, 8092 Zurich, Switzerland.
  • Cordey S; Department of Dermatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
  • Laubscher F; Department of Dermatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
  • Gonçalves AR; Department of Dermatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
  • Aeby S; Department of Dermatology, University Hospital Zurich, University of Zurich, 8091 Zurich, Switzerland.
  • Pillonel T; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
  • Jacot D; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
  • Bertelli C; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
  • Greub G; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
  • Leuzinger K; Institute of Medical Virology, University of Zurich, 8057 Zurich, Switzerland.
  • Stange M; Laboratory of Virology, Department of Diagnostics, Geneva University Hospitals & Faculty of Medicine, 1205 Geneva, Switzerland.
  • Mari A; Laboratory of Virology, Department of Diagnostics, Geneva University Hospitals & Faculty of Medicine, 1205 Geneva, Switzerland.
  • Roloff T; Swiss National Reference Centre for Influenza, University Hospitals of Geneva, 1205 Geneva, Switzerland.
  • Seth-Smith H; Institute of Microbiology, University Hospital Centre and University of Lausanne, 1011 Lausanne, Switzerland.
  • Hirsch HH; Institute of Microbiology, University Hospital Centre and University of Lausanne, 1011 Lausanne, Switzerland.
  • Egli A; Institute of Microbiology, University Hospital Centre and University of Lausanne, 1011 Lausanne, Switzerland.
  • Redondo M; Institute of Microbiology, University Hospital Centre and University of Lausanne, 1011 Lausanne, Switzerland.
  • Kobel O; Institute of Microbiology, University Hospital Centre and University of Lausanne, 1011 Lausanne, Switzerland.
  • Noppen C; Division of Clinical Virology, University Hospital Basel, 4051 Basel, Switzerland.
  • du Plessis L; Department of Biomedicine, University of Basel, 4031 Basel, Switzerland.
  • Beerenwinkel N; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
  • Neher RA; Department of Biomedicine, University of Basel, 4031 Basel, Switzerland.
  • Beisel C; Division of Clinical Bacteriology and Mycology, University Hospital Basel, 4031 Basel, Switzerland.
  • Stadler T; SIB Swiss Institute of Bioinformatics, 1015 Lausanne, Switzerland.
Sci Transl Med ; 15(680): eabn7979, 2023 01 25.
Article em En | MEDLINE | ID: mdl-36346321

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Sci Transl Med Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD Base de dados: MEDLINE Assunto principal: SARS-CoV-2 / COVID-19 Tipo de estudo: Prognostic_studies / Risk_factors_studies Aspecto: Patient_preference Limite: Humans País/Região como assunto: Europa Idioma: En Revista: Sci Transl Med Ano de publicação: 2023 Tipo de documento: Article